Alpha 2.0
Login Register
» Articles » PMID: 21784892

Circulating Anti-PLA2R Autoantibodies to Monitor Immunological Activity in Membranous Nephropathy

Overview
Journal J Am Soc Nephrol
Specialty Nephrology
Date 2011 Jul 26
PMID 21784892
Citations 12
Authors
Paolo Cravedi
Piero Ruggenenti
Giuseppe Remuzzi
Affiliations
Soon will be listed here.
Citing Articles

Diagnostic Usefulness of Antibodies Against M-type Phospholipase A2 Receptor (aPLA2R) in Primary Membranous Nephropathy in the Mexican Population.

Diaz Garcia Sr J Cureus. 2023; 15(8):e43588.

PMID: 37719622 PMC: 10503780. DOI: 10.7759/cureus.43588.

Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome.

Perna A, Ruggiero B, Podesta M, Perico L, Orisio S, Debiec H Front Pharmacol. 2022; 13:958136.

PMID: 36120314 PMC: 9479107. DOI: 10.3389/fphar.2022.958136.

Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy.

Spain R, Andeen N, Gibson P, Samuels M, Morris C, Solomon A Kidney Int. 2021; 100(6):1208-1213.

PMID: 34662650 PMC: 8628858. DOI: 10.1016/j.kint.2021.10.010.

Receptor antibody time-resolved A2 phospholipase bead immunochromatography and its application in idiopathic membranous nephropathy.

Huang B, Yang X, Zhang W, Wu J, Liu P, Hu Z J Clin Lab Anal. 2020; 34(12):e23508.

PMID: 32767448 PMC: 7755819. DOI: 10.1002/jcla.23508.

Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis.

Li W, Zhao Y Int Urol Nephrol. 2019; 51(9):1581-1596.

PMID: 31140029 DOI: 10.1007/s11255-019-02147-9.